Positron emission tomography molecular imaging for pathological visualization in multiple system atrophy.

Area of Science:

• Neuroscience
• Medical Imaging

Background:

• Multiple system atrophy (MSA) is a complex neurodegenerative disorder.
• Its hallmark is abnormal alpha-synuclein aggregation, causing neuroinflammation and system disruption.
• Brain metabolic abnormalities are also observed in MSA.

Purpose of the Study:

• To review the pathological mechanisms of MSA.
• To summarize relevant molecular targets and radiopharmaceuticals for PET imaging.
• To discuss clinical applications and future directions of PET in MSA.

Main Methods:

• Review of existing literature on MSA pathology and PET imaging.
• Identification of key pathological processes and molecular targets.
• Analysis of radiopharmaceuticals and their application in PET studies.

Main Results:

• PET imaging visualizes, characterizes, and quantifies MSA pathological processes.
• Radiolabeled agents enable diverse perspectives on molecular events.
• PET provides insights into MSA pathomechanisms.

Conclusions:

• PET molecular imaging is a promising tool for understanding MSA.
• Development of PET imaging biomarkers can enhance disease assessment and management.
• Further research into PET applications holds significant future potential for MSA.